tag patient-voice 
STAT
APRIL 12, 2024
The new legislation would also allow another state entity, the Rare Disease Advisory Council, to review such drugs in hopes of giving more voice to patients. The original bill was introduced over concerns that patients may lose access to rare disease drugs if companies halt sales or decide not to invest in developing such medicines.
FDA Law Blog: Biosimilars
JUNE 27, 2023
James’s status as a 15-year champion for bringing patient voices to the table with FDA and industry decision-makers was also considered. James is recognized as helping fundamentally shift the culture to consider the patient voice as an integral part of drug development. Dormer Jeffrey N. Gibbs Paul M. Hyman Alan M.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaState Academy
JUNE 24, 2023
Written By: Vivek Hattangadi The Voice of Your Brand: Create Your Brand’s Sonic Soul A tribute to Sylvester daCunha The creative genius Sylvester daCunha is no more. The ‘Voice of Brand Amul Butter’ is suddenly so soulful. What is the ‘Voice of your Brand’? That’s the power of sound in a tag line.
pharmaphorum
OCTOBER 3, 2022
‘Clearer’ data isn’t expected until 2024, with results from a late-stage phase 3 PHOENIX trial of around 600 patients due at that time. Following news of Relyvrio’s $158,000 annual price tag, both ALS advocates and outside observers have voiced outrage at the cost. ALS affects over 30,000 people in the US.
pharmaphorum
NOVEMBER 28, 2022
Owkin is committed to unlocking the vast potential held within patient data by developing technologies that overcome the privacy and security challenges that until now impacted research.”. Owkin in particular has bagged some high-profile, high-price tag development deals with the likes of Bristol-Myers Squibb and Sanofi.
pharmaphorum
MAY 24, 2021
Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. It can be used for sales, marketing and patient communication materials, in print or digital form.
pharmaphorum
AUGUST 17, 2020
In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Virtual connections. Engagement channels.
Expert insights. Personalized for you.
222 
Let's personalize your content